PRIME Scheme: EMA To Tackle Problem Of Premature Marketing Applications
‘Toolbox’ Guidance Is Also Being Finalized
Executive Summary
After finding that products developed under the PRIME scheme frequently lost their accelerated status while they were being reviewed for potential EU marketing approval, the European Medicines Agency is looking into whether it should start holding “submission readiness” meetings.